Upgrade to SI Premium - Free Trial

BioMarin Pharma (BMRN) Affirms Trading Halt Ahead of FDA Committee Review of Kyndrisa NDA

November 24, 2015 7:08 AM
BioMarin Pharma (NASDAQ: BMRN) announced today that NASDAQ has halted trading of the company’s stock. The Peripheral and Central ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Trader Talk Trading Halts

Next Articles